Nesiritide: Clinical Trials

44 trials of Nesiritide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 9 terminated, 5 withdrawn, 3 unknown. 15 Phase 2, 11 Phase 3, 9 Phase 1, 9 Phase 4, 6 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 215Completed 11, Terminated 3, Recruiting 1
Phase 311Completed 8, Terminated 1, Unknown 1, Withdrawn 1
Phase 19Completed 6, Terminated 2, Recruiting 1
Phase 49Terminated 5, Completed 3, Withdrawn 1
Not applicable6Completed 3, Withdrawn 2, Unknown 1
Early Phase 11Withdrawn 1

Follow Nesiritide: new trials by email Literature Review of Nesiritide trials Research Report on Nesiritide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nesiritide for Ventilated Congestive Heart Failure
Nesiritide - Congestive Heart Failure, Mechanical Ventilation
UnknownShanghai Zhongshan Hospital302020-05-142020-07-02
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Valsartan, LCZ696, Bradykinin - Hypertension
Phase 4TerminatedVanderbilt University Medical Center42018-11-152025-08-03
Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children
Nesiritide, Normal saline - Congenital Heart Disease, Total Cavo-pulmonary Connection
Not applicableUnknownChina National Center for Cardiovascular Diseases1082017-07-052017-07-06
Nesiritide in Hypertension
Nesiritide, Placebo - Hypertension
Phase 1 / Phase 2RecruitingOslo University Hospital152015-12-012018-01-03
Testosterone Regulation of the Natriuretic Peptide System
Testosterone, Nesiritide, Leuprolide - Hypertension
Not applicableWithdrawnMassachusetts General Hospital2015-02-012017-10-19
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Nesiritide, Saline - Obesity, Cardiovascular Disease
Phase 1CompletedAdventHealth Translational Research Institute42013-11-012018-02-14
Nesiritide and Renal Function After the Total Artificial Heart
nesiritide, placebo - Congestive Heart Failure, Cardiorenal Syndrome
Phase 4TerminatedVirginia Commonwealth University22013-04-012016-02-08
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
Nesiritide, Tadalafil, Placebo - Congestive Heart Failure
Phase 1 / Phase 2CompletedMayo Clinic432012-02-012018-03-22
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Sitagliptin (DPP4 inhibitor), Substance P,, bradykinin - Hypertension, Diabetes Type 2
Not applicableCompletedVanderbilt University442011-11-012015-11-04
Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study
Placebo, Nesiritide, Dopamine - Acute Heart Failure
Phase 2CompletedDuke University3602010-08-012014-08-21
Does Nesiritide Provide Renal Protection
Nesiritide, Placebo - Renal Failure
Phase 2CompletedUniversity of Florida372010-04-012014-06-06
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
BNP (nesiritide), Placebo - Left Ventricular Diastolic Dysfunction
Phase 1 / Phase 2CompletedMayo Clinic412008-03-012015-07-01
Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
nesiritide, milrinone, placebo - Heart Defects, Congenital
Phase 2TerminatedJohn M Costello1062007-10-012018-06-25
Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease
Nesiritide, Placebo - Heart Failure
Phase 3TerminatedThe Alfred62007-09-012015-06-25
Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF
Nesiritide - Heart Failure, Congestive, Dyspnea
Phase 4WithdrawnUniversity of Medicine and Dentistry of New Jersey2007-08-012015-11-11
A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
Nesiritide, Placebo - Heart Decompensation
Phase 3CompletedScios, Inc.71412007-05-012013-03-08
BNP Therapy Observation Unit Outcomes STudy (BOOST)
Nesiritide - Congestive Heart Failure
Phase 4TerminatedEmory University172007-03-012015-02-09
An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure
Nesiritide - Heart Decompensation, Congestive Heart Failure
Phase 3CompletedXian-Janssen Pharmaceutical Ltd.412006-10-012014-02-28
Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
Nesiritide, Placebo - Acute Myocardial Infarction
Phase 2CompletedMayo Clinic592006-09-012014-09-09
Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy
Nesiritide, Nitroglycerin - Acute Decompensated Heart Failure
Phase 4CompletedWestern University of Health Sciences892006-07-012013-08-30

Showing 20 of 44. Sign in to see all of them.

Conditions studied

Heart Failure (27)  ·  Renal Insufficiency (9)  ·  Cardiomyopathies (7)  ·  Hypertension (5)  ·  Dyspnea (4)  ·  Cardiovascular Diseases (3)  ·  Heart Defects, Congenital (3)  ·  Cardio-Renal Syndrome (2)  ·  Coronary Disease (2)  ·  Diabetes Mellitus (2)  ·  Dyspnea, Paroxysmal (2)  ·  Myocardial Ischemia (2)  ·  Obesity (2)  ·  Acute Kidney Injury (1)  ·  Cardiomyopathy, Dilated (1)

Sponsors

Scios, Inc. (9)  ·  Mayo Clinic (5)  ·  Horng Chen (3)  ·  Emory University (2)  ·  University of Wisconsin, Madison (2)  ·  Vanderbilt University Medical Center (2)  ·  AdventHealth Translational Research Institute (1)  ·  Boston Children's Hospital (1)  ·  Brigham and Women's Hospital (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  Duke University (1)  ·  Ejaz, Abulate A, MD (1)  ·  John M Costello (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)

Countries

United States (27)  ·  China (4)  ·  Australia (2)  ·  Canada (2)  ·  Norway (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Colombia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)

Top investigators

Horng H. Chen, M.D. (6)  ·  Adam H Miller (1)  ·  Alessandro Cataliotti, MD, PhD (1)  ·  Anju Nohria, MD (1)  ·  Daniel Wu, MD (1)  ·  Douglas Ander, MD (1)  ·  Duan Yabing, MD (1)  ·  Eugene Braunwald, MD (1)  ·  Henry Krum, MBBS FRACP PhD (1)  ·  Horng H Chen, MD (1)  ·  Janet M Simsic, MD (1)  ·  Jean-Bernard Durand, MD (1)  ·  John M Costello, MD (1)  ·  John M Costello, MD MPH (1)

Results publications

PMID 10400005, PMID 39878152, PMID 11911755, PMID 12486437, PMID 15342289, PMID 19660420, PMID 19752530, PMID 19808265, PMID 21362524, PMID 21576282, PMID 21732835, PMID 22157521, PMID 22497823, PMID 22595385, PMID 23032196, PMID 23122795, PMID 23770519, PMID 23899930, PMID 24046475, PMID 24054337, PMID 24247300, PMID 24464687, PMID 24516103, PMID 24622005, PMID 24906491, PMID 25074507, PMID 25158865, PMID 25281655, PMID 26304935, PMID 26874387, PMID 26927285, PMID 26988350, PMID 27512103, PMID 27514750, PMID 27623769, PMID 28641792, PMID 29431103, PMID 29781109, PMID 30354576, PMID 31606362, PMID 31909303, PMID 32473378, PMID 32747497, PMID 33775110, PMID 34405565, PMID 36314126, PMID 37725680

NIH funding

P01HL076611 (5), UL1RR024150 (5), R01HL084155 (2), 2015 (1), R01HL036634 (1), U01HL084904 (1)